share_log

Goldman Sachs Downgrades CME Gr to Sell, Announces $195 Price Target

Benzinga ·  Jan 3 04:56

Goldman Sachs analyst Alexander Blostein downgrades CME Gr (NASDAQ:CME) from Neutral to Sell and announces $195 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment